Citadel Advisors
SSKN

Citadel Advisors’s Strata Skin Sciences SSKN Stock Holding History

Citadel Advisors’s Portfolio SSKN Stock Details SSKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-7
Closed -$1K – 8387
2014
Q2 		$1K Buy
+7
New +$1.59K ﹤0.01% 7890
2014
Q1 		– Sell
-2
Closed -$1K – 8003
2013
Q4 		$1K Buy
+2
New +$716 ﹤0.01% 6942
2013
Q3 		– Sell
-7
Closed -$3K – 6856
2013
Q2 		$3K Buy
+7
New +$3.75K ﹤0.01% 6392

Other funds holding SSKN

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MOS
MGO One Seven Beachwood, Ohio $4.98B AUM 22.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AAM
Azzad Asset Management Falls Church, Virginia $1.13B AUM 38.47% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's SSKN Position: Q2 2025 in Review

Citadel Advisors sold out of Strata Skin Sciences (SSKN) in Q2 2025, closing a stake of 28,841 shares — an estimated $76.1K sold.

Citadel Advisors first reported a position in SSKN in Q2 2013 and held it in 21 quarters. The position peaked at $90.2K in Q4 2024. 16 funds tracked by Wall St. Rank hold SSKN as of Q2 2025.

  • Citadel Advisors reported no remaining Strata Skin Sciences position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 28,841 Strata Skin Sciences shares in Q2 2025, an estimated $76.1K.
  • Citadel Advisors first reported a position in Strata Skin Sciences in Q2 2013 and held it in 21 quarters.
  • Citadel Advisors's Strata Skin Sciences position peaked at $90.2K in Q4 2024.
  • 16 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.